Full-Time

Director – Product Management Commercial Technology

Posted on 11/1/2025

Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$135.4k - $208.1k/yr

+ Bonus

Company Does Not Provide H1B Sponsorship

United States

Hybrid

Category
Product (1)
Required Skills
Agile
Python
Product Management
SQL
JIRA
Confluence
Data Analysis
Requirements
  • Bachelor degree or equivalent experience in related field preferred
  • 12+ years of experience in product management, with a focus on commercial product development in healthcare or life sciences
  • Proven success in launching and scaling business-to-business healthcare products, preferably in oncology or specialty care
  • Strong understanding of healthcare delivery models, reimbursement, and value-based care in oncology
  • Experience working with cross-functional teams including clinical, technical, and commercial stakeholders, in addition to collaborating directly with customers
  • Familiarity with Agile methodologies and tools (e.g., Jira, Confluence)
  • Ability to collaborate, influence and lead cross functionally, including peer leadership
  • Excellent communication, strategic thinking, and problem-solving skills
  • Ability to collaborate with all levels of an organization, up to chief executive officer level
  • Ability to thrive in a fast-paced, mission-driven environment
  • Ability to travel up to ~10%
Responsibilities
  • Owner of the product lifecycle managing the products from ideation to launch, with a focus on delivering commercial-ready solutions
  • Drive a cohesive product vision by ensuring product features and design elements work together to form a clear and compelling value proposition
  • Accelerate time to market by focusing on product delivery of meaningful, testable iterations and identifying beta and pilot opportunities to gather early user feedback
  • Maintains and leverages relationships with external partners and vendors to ensure new product development is supported through the appropriate research and marketing efforts in order to bring products to market
  • Executes plans for innovating and driving market penetration of the new products through coordination among cross-functional teams, ensuring alignment across all parties
  • Use qualitative and quantitative data to prioritize features that drive adoption and engagement. Leverage customer feedback, marketing insights, and competitor analysis to inform product direction
  • Drive Product Lifecycle: Manage products from concept through launch, ensuring readiness for commercialization and scalability across diverse oncology practices
  • Market Intelligence & Opportunity Identification: Analyze market trends, competitive landscape, and customer feedback to identify opportunities for product innovation and differentiation
  • Cross-Functional Collaboration: Partner with clinical, commercial, engineering, and design teams to deliver solutions that meet both user needs and business objectives
  • Customer-Centric Development: Engage with oncology providers, administrators, and patients to gather insights and validate product concepts
  • Go-to-Market Enablement: Support launch planning, messaging, and sales enablement activities to ensure successful product adoption and market penetration
  • Performance Measurement: Define KPIs and success metrics to evaluate product performance, customer satisfaction, and commercial impact
Desired Qualifications
  • Proven success in launching and scaling B2B healthcare products, preferably in oncology or specialty care
  • Bachelor degree or equivalent experience in related field preferred

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for hospitals, clinics, and pharmacies worldwide. The company operates a global logistics network to deliver supplies while providing data tools that help healthcare facilities track inventory and improve operational efficiency. Unlike many niche suppliers, Cardinal Health combines 50 years of experience with a massive scale that covers both the physical supply chain and the software needed to manage it. Its goal is to streamline the healthcare supply chain to ensure providers have reliable access to essential products while reducing costs and improving patient care.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Majority stake in GI Alliance in November 2024 accelerates gastroenterology growth.
  • Acquired Advanced Diabetes Supply Group in November 2024 boosts at-Home Solutions.
  • Added Solaris Health urology MSO in August 2025 to Specialty Alliance platform.

What critics are saying

  • McKesson erodes specialty share with superior pharmacy analytics within 12-24 months.
  • Cencora undercuts generics pricing, squeezing margins in 6-12 months.
  • DEA quotas cut $500M opioid revenue comprising 20% sales in 3-6 months.

What makes Cardinal Health unique

  • Acquired Specialty Networks in January 2024 for multi-specialty GPOs in urology and gastroenterology.
  • Launched Kendall DL™ Multi System in June 2025 for continuous vital signs monitoring.
  • Expanded Actinium-225 production in April 2026 for novel cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...

INACTIVE